A novel small molecule BAX activator as an oral therapeutic for the treatment of lung cancer
Ended Project Grant Awarded Last action
- Award ID
- R43CA232808
- Recipient
-
Nanometics LLC UEI PM3SN3WEQW86
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,676
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- New York, NY 10014, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $299,676 |
Quick answers
Who received award R43CA232808?
R43CA232808 was awarded to Nanometics LLC by National Cancer Institute (National Institutes of Health) on April 22, 2019.
How much is award R43CA232808 worth?
$299,676 has been obligated on R43CA232808.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award